Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 28-34

  Leinonen, J ^a   Zhang, W M ^a   Paus, E ^b   Stenman, U H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antibodies; Prostate specific antigen; TD 3 Workshop

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ISOENZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 165; MONOCLONAL ANTIBODY 1A5 6; MONOCLONAL ANTIBODY 2E9; MONOCLONAL ANTIBODY 2H11; MONOCLONAL ANTIBODY 365; MONOCLONAL ANTIBODY 4G10; MONOCLONAL ANTIBODY 4H5; MONOCLONAL ANTIBODY 5A10; MONOCLONAL ANTIBODY 92 28464; MONOCLONAL ANTIBODY 9B10; MONOCLONAL ANTIBODY E74; MONOCLONAL ANTIBODY E86; MONOCLONAL ANTIBODY E87; MONOCLONAL ANTIBODY E91; MONOCLONAL ANTIBODY H117; MONOCLONAL ANTIBODY M704; MONOCLONAL ANTIBODY PR1; MONOCLONAL ANTIBODY PR12; MONOCLONAL ANTIBODY PS72; MONOCLONAL ANTIBODY PS80; MONOCLONAL ANTIBODY PS98; MONOCLONAL ANTIBODY PSA30; MONOCLONAL ANTIBODY PSB999; MONOCLONAL ANTIBODY PSS101; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; CLASSIFICATION; COMPLEX FORMATION; CONFERENCE PAPER; CROSS REACTION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032703334     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056527     Document Type: Conference Paper

References (21)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate specific antigen. Invest Urol 1979;17:159-163.
2. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkarten K, Alfthan O: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-226.
3. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lövgren T: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991;37: 1618-1625.
4. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett AT, Abrahamsson PA, Lilja H: Serum prostate specific antigen complexed to alpha-1antichymotrypsin as an indicator of prostate cancer. J Urol 1993;A50:100-105.
5. Espana F, Gilabert J, Estelles A, Romeu A, Aznar J, Cabo A: Functionally active protein C inhibitor/ plasminogen activator inhibitor-3 (PC1/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991;64:309-320.
6. Christensson A, Laurell CB, Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194: 755-763.
7. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL: Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39: 2483-2491.
8. Zhang W-M, Finne P, Leinonen J, Vesalainen S, Nordling S, Rannikko S, Stenman UK: Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin. Clin Chem 1998;44:2471-2479.
9. Watt KW, Lee P-J, M'Tirnkulu T, Chan W-P, Loor R: Human prostate specific antigen: Structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986;83:3166-3170.
10. Zhang W-M, Leinonen J, Kalkkinen N, Dowell B, Stenman UH: Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 1995;41:1567-1573.
11. Leinonen J, Zhang W-M, Stenman U-H: Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996;155:1099-1103.
12. Stenman U-H, Leinonen J, Zhang W-M: Standardization of PSA determinations. Scand J Clin Lab Invest Suppl 1995;221:45-51.
13. Noldus J, Chen Z, Stamey TA: Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer. J Urol 1997;158:1606-1609.
14. Zhang W-M, Leinonen J, Stenman U-H: PSA forms a complex with and cleaves alpha-1-protease inhibitor in vitro. Prostate 1997;33:87-96.
15. Mitrunen K, Pettersson K, Piironen T, Bjork T, Lilja H, Lövgren T: Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem 1995;41:1115-1120.
16. Pettersson K, Phronen T, Seppala M, Liukkonen L, Christensson A, Matikainen MT, Suonpaa M, Lovgren T, Lilja H: Free and complexed prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha-1-antichymotrypsin complex. Clin Chem 1995;41:1480-1488.
17. Paus E, Nustad K, Børmer OP: Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen. Tumor Biol 1999;20(suppl 1):52-69.
18. Piironen T, Villoutreix BO, Becker C, Hollingsworth K, Vihinen M, Bridon D, Qiu X, Rapp J, Dowell B, Lovgren T, Pettersson K, Lilja H: Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Protein Sci 1998;7:259-269.
19. Stamey TA, Chen Z, Prestigiacomo A: Serum prostate specific antigen binding alpha-1-antichymotrypsin: Influence of cancer volume, location and therapeutic selection of resistant clones. J Urol 1994;152:1510-1514.
20. Tewari PC, Williams JS: Analytical characteristics of seminal fluid PSA differ from those of serum PSA. Clin Chem 1998;44:191-193.
21. Huber PR, Schmid HP, Mattarelli G, Strittmatter B, van Steenbrugge GJ, Maurer A: Serum free prostate specific antigen: Isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 1995;27:212-219.